Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1CNS 1

Conditions

Prostatic Neoplasms 1Oligodendroglioma 1Glioma 1Astrocytoma 1

Interventions

Specimen Handling 115Magnetic Resonance Spectroscopy 91Carboplatin 61pembrolizumab 59Biopsy 59Cisplatin 53Nivolumab 49Paclitaxel 41Radiotherapy 39Cyclophosphamide 38Gemcitabine 35Dexamethasone 31Radiation 30Bevacizumab 30Pemetrexed 29atezolizumab 27Etoposide 27olaparib 24Lenalidomide 24Docetaxel 24Doxorubicin 23venetoclax 22durvalumab 22X-Rays 22Vincristine 22Rituximab 22Prednisone 22Leucovorin 22Immunoglobulin G 22Disulfides 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Protons × 30 days × Clear all
NCT04190446 2026-06-04

A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer

Mayo Clinic

Phase 2 Active not recruiting
84 enrolled
Genitourinary

Prostatic Neoplasms

NCT03180502 2026-05-26

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

NRG Oncology

Phase 2 Active not recruiting
120 enrolled
CNS

Astrocytoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡